,OR,p,FDR
Hypothyroidism,10.75713453698311,1.2871253814626447e-07,True
"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)",9.21,1.3843815395143475e-07,True
Eosinophil counts,3.958386533163094,2.706401055195956e-06,True
Systemic lupus erythematosus,5.997574468085106,7.108919197216251e-06,True
Multiple sclerosis,4.37525,0.0001086540638280082,True
Mouth ulcers,10.750579278384642,0.00017217415782346093,True
Itch intensity from mosquito bite,9.278158947970269,0.00032620480215922665,False
Psoriasis,6.6,0.00048184760511179697,False
Inflammatory bowel disease,4.592546194801128,0.000628867178094267,False
Rheumatoid arthritis (ACPA-positive),10.340823225293299,0.0008831824758682089,False
Myeloid white cell count,5.767857142857143,0.0009415630718805478,False
Systemic sclerosis,10.12461059190031,0.000950619731259597,False
Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies),17.23148148148148,0.0010391040168774035,False
White blood cell count,2.699142156862745,0.0011667922989123565,False
Tonsillectomy,5.385192909280501,0.0013178718920583863,False
Medication use (thyroid preparations),6.2331536388140165,0.0017723067663577834,False
Rheumatoid arthritis,4.946883988494727,0.0019868398653751663,False
Ulcerative colitis,4.722344322344322,0.0024805766092717576,False
Blood protein levels in cardiovascular risk,7.58411214953271,0.00257933245626811,False
Monocyte percentage of white cells,4.545326278659612,0.0029728286499307826,False
Atypical femoral fracture in phosphonate treatment,29.908256880733944,0.0030361021512018784,False
Bone mineral content,23.922935779816513,0.0044041644870753145,False
Celiac disease,6.466292834890965,0.004433969301828827,False
Asthma,3.245074009231259,0.004972463104592936,False
Non-albumin protein levels,8.401162790697674,0.0068138076097972395,False
Granulocyte percentage of myeloid white cells,4.055974842767296,0.01002662996231816,False
Eosinophilic esophagitis,14.064759848893686,0.010980445095085542,False
Adult asthma,13.28236493374108,0.012133849456001279,False
Allergic sensitization,12.582327378078222,0.013337887160613758,False
Eczema,3.752038201723736,0.013516435703781481,False
Nevus count or cutaneous melanoma,11.952293577981651,0.014591637930171158,False
Hypertension,4.204144656643641,0.018152251158284602,False
Alanine transaminase levels,10.390905464698843,0.018642140251015855,False
Hay fever and/or eczema,4.061572292468389,0.02023314112960933,False
Granulocyte count,3.8962918299668376,0.023033543464769678,False
Autoimmune traits (pleiotropy),9.189837685250529,0.02310803667557007,False
Primary biliary cirrhosis,9.189837685250529,0.02310803667557007,False
Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),9.189837685250529,0.02310803667557007,False
Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular),9.189837685250529,0.02310803667557007,False
Fasting plasma glucose,8.848793747876316,0.024684976019425955,False
SjÃ¶gren's syndrome,8.53211009174312,0.026304675967276786,False
Sum basophil neutrophil counts,3.6027339935834846,0.029313402197050212,False
Psoriasis vulgaris,7.962079510703364,0.0296690894417764,False
Neutrophil percentage of granulocytes,3.52302339859472,0.03137677998763881,False
"Allergic disease (asthma, hay fever or eczema)",3.446728971962617,0.03352384804004328,False
Itch intensity from mosquito bite adjusted by bite size,3.446728971962617,0.03352384804004328,False
Asthma or allergic disease (pleiotropy),7.236586043925493,0.035016262643045803,False
Diastolic blood pressure (cigarette smoking interaction),7.023205612520237,0.036875678262887804,False
Scarlet fever,7.023205612520237,0.036875678262887804,False
Eosinophil percentage of granulocytes,3.2583985855013893,0.039660883832822055,False
Systolic blood pressure (cigarette smoking interaction),6.281989377112506,0.04467831327314341,False
Sum eosinophil basophil counts,3.0893841361131082,0.0463987365973958,False
Albumin-globulin ratio,6.120442248882616,0.046716547157937445,False
Medication use (beta blocking agents),6.120442248882616,0.046716547157937445,False
Neutrophil count,3.030388526420972,0.04908030179026181,False
Monocyte count,2.9735779393100263,0.05184609680502397,False
Glucose homeostasis traits,5.422852376980817,0.05739779223478864,False
Family history of Alzheimer's disease,5.422852376980817,0.05739779223478864,False
Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),5.301936799184506,0.05962728166878828,False
Ocular sarcoidosis,5.186278420422816,0.061886301618533666,False
Infant length,13.17070707070707,0.08124869149144505,False
B-cell acute lymphoblastic leukaemia,13.17070707070707,0.08124869149144505,False
Response to methotrexate in juvenile idiopathic arthritis,13.17070707070707,0.08124869149144505,False
Alanine aminotransferase levels in low alcohol consumption,13.17070707070707,0.08124869149144505,False
Mammographic density (dense area),13.17070707070707,0.08124869149144505,False
Cutaneous psoriasis,13.17070707070707,0.08124869149144505,False
Age-related diseases and mortality,13.17070707070707,0.08124869149144505,False
Nevus count,13.17070707070707,0.08124869149144505,False
Lung cancer,3.0179738562091503,0.08408813116293318,False
Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test),4.181876710123934,0.08850568040130811,False
HDL cholesterol levels x short total sleep time interaction (2df test),4.181876710123934,0.08850568040130811,False
Response to anti-depressant treatment in major depressive disorder,11.852727272727273,0.08900452047100722,False
Sum neutrophil eosinophil counts,2.871777777777778,0.09385825340305884,False
Mean arterial pressure,2.8487654320987654,0.09553058006589006,False
Plateletcrit,2.3773480151753494,0.09653495346440122,False
Irritable bowel syndrome,10.774380165289257,0.09669546192352821,False
Loneliness (linear analysis),10.774380165289257,0.09669546192352821,False
IgG N-glycosylation phenotypes (multivariate analysis),10.774380165289257,0.09669546192352821,False
Chronic hepatitis B infection,10.774380165289257,0.09669546192352821,False
Phoneme awareness,10.774380165289257,0.09669546192352821,False
"Facial morphology (factor 13, vertical position of alar curvature relative to upper lip)",10.774380165289257,0.09669546192352821,False
Non-alcoholic fatty liver disease histology (other),10.774380165289257,0.09669546192352821,False
IgE levels,10.774380165289257,0.09669546192352821,False
Prostate cancer (early onset),10.774380165289257,0.09669546192352821,False
Mean corpuscular volume,2.097330878969167,0.10082510387889301,False
Crohn's disease,2.3304600308501953,0.10176478874903051,False
Autoimmune traits,3.781855249745158,0.10421368567655245,False
Thalamus volume,9.875757575757575,0.10432205382644776,False
Systemising,9.875757575757575,0.10432205382644776,False
Platelet count,2.060609976738175,0.10637099013009545,False
Inflammatory skin disease,3.7224770642201834,0.10690169789131967,False
Vitiligo,3.664925899788285,0.1096083420048411,False
Systemic lupus erythematosus and Systemic sclerosis,9.115384615384615,0.11188482972748696,False
Potassium levels,9.115384615384615,0.11188482972748696,False
IgA levels,9.115384615384615,0.11188482972748696,False
N-glycan levels,9.115384615384615,0.11188482972748696,False
antipsychotic drug dosage in schizophrenia or schizoaffective disorder,9.115384615384615,0.11188482972748696,False
IgM levels,9.115384615384615,0.11188482972748696,False
Medication use (agents acting on the renin-angiotensin system),2.6372549019607843,0.11290848391626243,False
Alzheimer's disease (late onset),3.5024284943335133,0.11783511768918381,False
Blood pressure traits (multi-trait analysis),8.463636363636363,0.119384318802383,False
Response to angiotensin II receptor blocker therapy,8.463636363636363,0.119384318802383,False
Fear of minor pain,8.463636363636363,0.119384318802383,False
High density lipoprotein cholesterol levels,2.1598046644775617,0.12394528436102265,False
Prostate cancer,2.47183908045977,0.12949779800782577,False
Medication use (diuretics),3.261279376649491,0.13187388893125054,False
"Facial morphology (factor 15, philtrum width)",7.404545454545454,0.13419553144844817,False
QRS complex (12-leadsum),7.404545454545454,0.13419553144844817,False
Simvastatin-induced myopathy,7.404545454545454,0.13419553144844817,False
Fibroblast growth factor basic levels,7.404545454545454,0.13419553144844817,False
Kawasaki disease,7.404545454545454,0.13419553144844817,False
Lymphocyte counts,2.421171171171171,0.13521127431487343,False
Alzheimer's disease or family history of Alzheimer's disease,3.1738226299694188,0.13759329228460632,False
Waist-to-hip ratio adjusted for body mass index,3.1738226299694188,0.13759329228460632,False
Eosinophil percentage of white cells,2.372516556291391,0.1410110427580828,False
Calcific aortic valve stenosis,6.968449197860963,0.14150829175826335,False
Waist-to-hip ratio adjusted for BMI (age >50),6.968449197860963,0.14150829175826335,False
Waist-to-hip ratio adjusted for BMI x sex interaction,6.968449197860963,0.14150829175826335,False
Mean platelet volume,2.047128364885374,0.14181959879221323,False
IgG glycosylation,2.020742142828976,0.14644226567802668,False
Airway responsiveness in chronic obstructive pulmonary disease,6.58080808080808,0.148759838796583,False
Alzheimer's disease in APOE e4- carriers,6.58080808080808,0.148759838796583,False
Response to paliperidone in schizophrenia (Multivariate),6.233971291866029,0.15595068034135928,False
Celiac disease and Rheumatoid arthritis,6.233971291866029,0.15595068034135928,False
Bladder cancer,5.921818181818182,0.1630813199985436,False
IgA nephropathy,5.921818181818182,0.1630813199985436,False
Colorectal adenoma (advanced),5.921818181818182,0.1630813199985436,False
Platelet-derived growth factor BB levels,5.921818181818182,0.1630813199985436,False
Hodgkin's lymphoma,5.921818181818182,0.1630813199985436,False
Medication use (calcium channel blockers),2.831804281345566,0.1639519093189551,False
Type 1 diabetes,2.7982730706961685,0.16693532599283173,False
Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event),5.63939393939394,0.17015225723830948,False
HIV-1 viral setpoint,5.63939393939394,0.17015225723830948,False
Serum albumin level,5.63939393939394,0.17015225723830948,False
Dupuytren's disease,5.63939393939394,0.17015225723830948,False
Age-related hearing impairment,5.63939393939394,0.17015225723830948,False
Allergy,5.63939393939394,0.17015225723830948,False
Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),5.3826446280991735,0.1771639874294954,False
Waist-to-hip ratio adjusted for BMI in non-smokers,5.148221343873518,0.18411700184552765,False
Heschl's gyrus morphology,5.148221343873518,0.18411700184552765,False
Methadone dose in opioid dependence,5.148221343873518,0.18411700184552765,False
Melanoma,4.933333333333334,0.191011787744905,False
Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),4.933333333333334,0.191011787744905,False
Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test),4.933333333333334,0.191011787744905,False
Respiratory diseases,2.5559830324553614,0.19111529169448666,False
Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1),4.735636363636363,0.19784882836451467,False
Interleukin-12p70 levels,4.735636363636363,0.19784882836451467,False
Smooth-surface caries,4.735636363636363,0.19784882836451467,False
Polycystic ovary syndrome,4.735636363636363,0.19784882836451467,False
Asthma (moderate or severe),4.5531468531468535,0.20462860298466673,False
Aspartate aminotransferase levels in low alcohol consumption,4.5531468531468535,0.20462860298466673,False
Mosquito bite size,2.3757798165137616,0.21263293872529385,False
Interleukin-18 levels,4.2272727272727275,0.21801825159772878,False
Loneliness,4.2272727272727275,0.21801825159772878,False
Plasma factor VII activating protease levels,4.2272727272727275,0.21801825159772878,False
Mean corpuscular hemoglobin,1.3934817170111289,0.21809630776873618,False
Mean corpuscular hemoglobin concentration,2.328836121604605,0.2188262929503279,False
Red cell distribution width,1.4192826719823322,0.2209645517807644,False
Diisocyanate-induced asthma,2.3060479201923934,0.22192905659565804,False
Neutrophil percentage of white cells,2.3060479201923934,0.22192905659565804,False
Pulse pressure x alcohol consumption interaction (2df test),4.081191222570533,0.224629064551191,False
Takayasu arteritis,4.081191222570533,0.224629064551191,False
Selective IgA deficiency,4.081191222570533,0.224629064551191,False
Leprosy,4.081191222570533,0.224629064551191,False
Protein quantitative trait loci,3.944848484848485,0.23118448947326675,False
Perceived unattractiveness to mosquitoes,3.944848484848485,0.23118448947326675,False
Parental longevity (mother's age at death or mother's attained age),3.944848484848485,0.23118448947326675,False
Creatine kinase levels,3.817302052785924,0.23768498625247092,False
Lymphocyte percentage of white cells,2.178099486575204,0.24061322244148092,False
Night sleep phenotypes,2.178099486575204,0.24061322244148092,False
Neurofibrillary tangles,3.6977272727272728,0.24413101097448045,False
Clostridium difficile infection in multiple myeloma,3.6977272727272728,0.24413101097448045,False
Waist-to-hip ratio adjusted for BMI in active individuals,3.6977272727272728,0.24413101097448045,False
Total cholesterol levels,1.6049592498190628,0.24918315123542267,False
Carotid plaque burden,3.5853994490358128,0.25052301598018084,False
Psoriatic arthritis,3.5853994490358128,0.25052301598018084,False
Atopic asthma,2.0455552040493514,0.26250206582821833,False
Osteoarthritis,3.38,0.26314675766350776,False
Bone mineral density,3.38,0.26314675766350776,False
Breast cancer (estrogen-receptor negative),3.38,0.26314675766350776,False
Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction),3.285858585858586,0.2693793805401822,False
Skin pigmentation,3.285858585858586,0.2693793805401822,False
Asthma onset (childhood vs adult),3.285858585858586,0.2693793805401822,False
Lateral ventricle temporal horn volume,3.196805896805897,0.2755597561475348,False
Pediatric autoimmune diseases,3.11244019138756,0.28168831852954007,False
Acute lymphoblastic leukemia (childhood),3.11244019138756,0.28168831852954007,False
Advanced age-related macular degeneration,3.0324009324009324,0.28776549815309055,False
Dental caries,3.0324009324009324,0.28776549815309055,False
Aspartate aminotransferase levels,3.0324009324009324,0.28776549815309055,False
Triglyceride levels x short total sleep time interaction (2df test),2.9563636363636365,0.2937917219284948,False
Stroke,2.9563636363636365,0.2937917219284948,False
Pneumonia,2.8840354767184038,0.29976741325788453,False
"Age-related diseases, mortality and associated endophenotypes",2.8840354767184038,0.29976741325788453,False
HDL cholesterol levels x long total sleep time interaction (2df test),2.815151515151515,0.30569299205475137,False
Alcohol dependence,2.7494714587737845,0.31156887479176015,False
Mean arterial pressure x alcohol consumption interaction (2df test),2.6867768595041324,0.3173954744759428,False
"Medication use (adrenergics, inhalants)",2.6867768595041324,0.3173954744759428,False
Red blood cell traits,2.6867768595041324,0.3173954744759428,False
Pulse pressure,1.3109305373525557,0.3208683193593368,False
Bipolar I disorder,2.626868686868687,0.32317320074893474,False
Testicular germ cell tumor,2.626868686868687,0.32317320074893474,False
Blood protein levels,1.1727917209908736,0.3248415046171706,False
Response to amphetamines,2.5695652173913044,0.3289024598559571,False
Smoking behaviour (cigarettes smoked per day),2.5695652173913044,0.3289024598559571,False
Obesity-related traits,1.2960331864143115,0.3298589394763023,False
LDL cholesterol levels in current drinkers,2.5147001934235975,0.3345836547076544,False
White matter microstructure (mode of anisotropy),2.5147001934235975,0.3345836547076544,False
Primary biliary cholangitis,2.462121212121212,0.34021718489913155,False
Fibrinogen levels,2.411688311688312,0.3458034467266938,False
Triglyceride levels,1.6558670687111054,0.3464788769863001,False
3-hydroxypropylmercapturic acid levels in smokers,1.6442405708460754,0.3495447168814859,False
Adverse response to drug,2.363272727272727,0.35134283321289966,False
Ease of getting up in the morning,2.3167557932263816,0.35683573414406955,False
Red blood cell count,1.2067875029224655,0.35850590596960297,False
Amyotrophic lateral sclerosis,2.272027972027972,0.36228253612136807,False
Lean body mass,2.272027972027972,0.36228253612136807,False
Cardiovascular disease,1.4104938271604939,0.3646620522495493,False
Myopia (pathological),2.2289879931389365,0.3676836225374674,False
Systolic blood pressure x alcohol consumption interaction (2df test),2.1875420875420875,0.37303937361112394,False
Pursuit maintenance gain,2.1875420875420875,0.37303937361112394,False
Blood pressure,2.147603305785124,0.378350166464208,False
Alcohol consumption,2.109090909090909,0.3836163750781654,False
Diastolic blood pressure x alcohol consumption interaction (2df test),2.109090909090909,0.3836163750781654,False
Platelet distribution width,1.496922540936012,0.3919121804579926,False
Cigarettes smoked per day (MTAG),2.0360501567398117,0.39401652019926586,False
Triglyceride levels in current drinkers,2.0360501567398117,0.39401652019926586,False
Glycated hemoglobin levels,2.001386748844376,0.3991511893853384,False
Nonatopic asthma,1.9678787878787878,0.4042427397286982,False
Post bronchodilator FEV1,1.4504418303596556,0.4067548219843378,False
Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),1.9354694485842028,0.4092915300809687,False
LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),1.9041055718475073,0.4142979162799201,False
Uterine fibroids,1.8737373737373737,0.4192622512821095,False
Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),1.8737373737373737,0.4192622512821095,False
LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),1.8443181818181817,0.4241848851254869,False
Allergic rhinitis,1.8158041958041957,0.4290661649287445,False
Bitter alcoholic beverage consumption,1.7613297150610583,0.4387060366915668,False
Cervical cancer,1.7613297150610583,0.4387060366915668,False
Rosacea symptom severity,1.7100131752305665,0.44818458684142254,False
Lung cancer in ever smokers,1.6854545454545455,0.45286420413891,False
Asthma (adult onset),1.6854545454545455,0.45286420413891,False
Bipolar disorder and schizophrenia,1.6615877080665813,0.4575044909257518,False
Alzheimer's disease,1.6615877080665813,0.4575044909257518,False
PR interval in Tripanosoma cruzi seropositivity,1.6615877080665813,0.4575044909257518,False
Late-onset Alzheimer's disease,1.5938574938574939,0.4711926303998004,False
Balding type 1,1.2688172043010753,0.47264221031968956,False
Lifetime smoking index,1.5516746411483253,0.4801273380397687,False
Waist-hip ratio,1.0881720430107527,0.4809929876265579,False
Bipolar disorder,1.2351217637734762,0.4863898778221686,False
Myopia (age of diagnosis),1.5116550116550116,0.48891242243731964,False
Asthma (childhood onset),1.2285932721712538,0.48911303297438663,False
White matter microstructure (radial diusivities),1.455331088664422,0.5018149263440526,False
Body fat distribution (trunk fat ratio),1.4374722838137473,0.5060436135796061,False
Coffee consumption,1.4374722838137473,0.5060436135796061,False
Birth weight,1.1727600529462778,0.513215719528594,False
Parkinson's disease or first degree relation to individual with Parkinson's disease,1.403030303030303,0.5143945649425792,False
Creatinine levels,1.3701902748414376,0.5226055836049622,False
White matter microstructure (fractional anisotropy),1.3543364681295715,0.5266593458463551,False
Longevity,1.308888888888889,0.538617079820473,False
LDL cholesterol levels,1.308888888888889,0.538617079820473,False
Neuroticism,1.057385229540918,0.5440619999628912,False
Lobe attachment (rater-scored or self-reported),1.2802371541501976,0.546422090926262,False
Male-pattern baldness,1.044543063773833,0.5520990605328547,False
Serum uric acid levels,1.2265151515151516,0.5616416945138989,False
"anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)",1.1770909090909092,0.5763550584496305,False
Coronary artery disease,0.9989770223481271,0.5814925106172013,False
Immature fraction of reticulocytes,1.1314685314685315,0.5905788734711148,False
Offspring birth weight,1.1206060606060606,0.5940602389427414,False
Systolic blood pressure,0.9284188034188035,0.6297651341627215,False
Diastolic blood pressure,0.909754105798022,0.6425750952632375,False
Adolescent idiopathic scoliosis,0.9049216589861752,0.6515022487822393,False
Core binding factor acute myeloid leukemia,0.8807187780772686,0.675696970587222,False
Waist circumference,0.8442773054283845,0.6964731027779276,False
High light scatter reticulocyte percentage of red cells,0.8321727917472598,0.7016269766212704,False
Reticulocyte count,0.8089655172413793,0.7116759586927877,False
High light scatter reticulocyte count,0.7978354978354978,0.7165739364171143,False
Reticulocyte fraction of red cells,0.7978354978354978,0.7165739364171143,False
3-hydroxy-1-methylpropylmercapturic acid levels in smokers,0.7978354978354978,0.7165739364171143,False
Weight,0.7611570247933884,0.7330763926388641,False
Breast cancer,0.78125,0.738082511358668,False
Menarche (age at onset),0.7465486414397514,0.7484830432438894,False
Atrial fibrillation,0.7231200897867565,0.7507729904647389,False
Hair color,0.7298165137614679,0.759360032926014,False
Hip circumference adjusted for BMI,0.6805496828752643,0.7712667253519941,False
Reaction time,0.7027744003537084,0.7770703531552559,False
Self-reported math ability,0.6984562984123496,0.7799100138144202,False
Major depressive disorder,0.6610683102208526,0.7808781633058273,False
"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)",0.6573033707865169,0.7827518651766693,False
Low density lipoprotein cholesterol levels,0.6355731225296443,0.7936652496396601,False
LDL cholesterol,0.6218568665377177,0.8006371894661832,False
Waist-to-hip ratio adjusted for BMI,0.6809904615088159,0.8346653593886562,False
Highest math class taken,0.5530805687203791,0.8364249730760298,False
Urate levels,0.5350291909924938,0.8459949969010065,False
C-reactive protein levels,0.5816835667149525,0.8565100643606457,False
HDL cholesterol,0.511164274322169,0.8587114253472279,False
Estimated glomerular filtration rate,0.5713381841189497,0.8631321501557535,False
Lung function (FEV1/FVC),0.6114540466392319,0.8651349882061654,False
Metabolite levels,0.6774384236453201,0.8700432100984002,False
Triglycerides,0.4750649350649351,0.8779850514942649,False
Schizophrenia,0.5928462709284628,0.8780337627709975,False
Intelligence,0.4653818181818182,0.8831406454293589,False
Post bronchodilator FEV1/FVC ratio,0.4100546097012528,0.9121517388958272,False
Chronotype,0.3889566809029896,0.9228571441588417,False
Waist circumference adjusted for body mass index,0.46804225566195473,0.9512875126492384,False
Cognitive performance (MTAG),0.29273652556095303,0.9662467288464293,False
Height,0.5807744556080109,0.9779682952438972,False
Highest math class taken (MTAG),0.3379204892966361,0.9799384471689381,False
Self-reported math ability (MTAG),0.24490948024138604,0.9823467175164371,False
Lung function (FVC),0.2295774647887324,0.9864406825303141,False
Body mass index,0.40671787165358714,0.9920272985982499,False
Heel bone mineral density,0.30658056580565807,0.9958883559818441,False
General cognitive ability,0.17311827956989248,0.9965350674975949,False
Educational attainment (MTAG),0.13486319505736982,0.9992667674029907,False
Educational attainment (years of education),0.12851719046614637,0.9994802153187031,False
Eotaxin levels,0.0,1.0,False
Nicotine withdrawal symptom count,0.0,1.0,False
Feeling fed-up,0.0,1.0,False
Coenzyme Q10 levels,0.0,1.0,False
Blood urea nitrogen levels,0.0,1.0,False
Interleukin-2 receptor antagonist levels,0.0,1.0,False
Cuneus cortex volume,0.0,1.0,False
Inferior parietal cortex volume,0.0,1.0,False
Lingual gyrus volume,0.0,1.0,False
Cannabis dependence symptom count,0.0,1.0,False
Worry too long after an embarrassing experience,0.0,1.0,False
Feeling nervous,0.0,1.0,False
Medial orbital frontal cortex volume,0.0,1.0,False
Parental longevity (mother's age at death),0.0,1.0,False
Interleukin-4 levels,0.0,1.0,False
Parental extreme longevity (95 years and older),0.0,1.0,False
Pelvic organ prolapse (moderate/severe),0.0,1.0,False
Lactate dehydrogenase levels,0.0,1.0,False
Subjective response to placebo treatment in childhood asthma (change in cough/wheeze),0.0,1.0,False
Gestational age at birth (child effect),0.0,1.0,False
Interleukin-8 levels,0.0,1.0,False
Gestational age at birth in labor-initiated deliveries (child effect),0.0,1.0,False
Gastroesophageal reflux disease,0.0,1.0,False
Clopidogrel active metabolite levels,0.0,1.0,False
Type 2 diabetes (age of onset),0.0,1.0,False
Childhood body mass index,0.0,1.0,False
Total body bone mineral density (age over 60),0.0,1.0,False
Interleukin-9 levels,0.0,1.0,False
Total body bone mineral density (age 45-60),0.0,1.0,False
Total body bone mineral density,0.0,1.0,False
Cerebrospinal fluid biomarker levels,0.0,1.0,False
Osteoarthritis of the hip or knee,0.0,1.0,False
Parental lifespan,0.0,1.0,False
Urinary metabolite levels in chronic kidney disease,0.0,1.0,False
Pediatric bone mineral density (femoral neck),0.0,1.0,False
CTACK levels,0.0,1.0,False
Total triglycerides levels,0.0,1.0,False
Interleukin-6 levels,0.0,1.0,False
Cardiometabolic and hematological traits,0.0,1.0,False
High altitude adaptation,0.0,1.0,False
Growth-regulated protein alpha levels,0.0,1.0,False
Common carotid intima-media thickness in HIV negative individuals,0.0,1.0,False
Daytime sleep phenotypes,0.0,1.0,False
Hepcidin/ferritin ratio,0.0,1.0,False
Granulocyte-colony stimulating factor levels,0.0,1.0,False
Interleukin-1-receptor antagonist levels,0.0,1.0,False
Disease progression in age-related macular degeneration,0.0,1.0,False
Hepatocyte growth factor levels,0.0,1.0,False
Interferon gamma levels,0.0,1.0,False
"Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)",0.0,1.0,False
Disease progression in age-related macular degeneration (adjusted for baseline),0.0,1.0,False
Epstein-Barr virus copy number in lymphoblastoid cell lines,0.0,1.0,False
Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event),0.0,1.0,False
Response to cognitive-behavioural therapy in anxiety disorder,0.0,1.0,False
"Response to radiotherapy in prostate cancer (toxicity, urinary frequency)",0.0,1.0,False
Interleukin-2 levels,0.0,1.0,False
Mortality in sepsis,0.0,1.0,False
beta-nerve growth factor levels,0.0,1.0,False
Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome),0.0,1.0,False
Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,0.0,1.0,False
Posterior cortical atrophy and Alzheimer's disease,0.0,1.0,False
Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,0.0,1.0,False
Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,0.0,1.0,False
Systemic juvenile idiopathic arthritis,0.0,1.0,False
Parental longevity (combined parental age at death),0.0,1.0,False
Huntington's disease progression,0.0,1.0,False
Interleukin-7 levels,0.0,1.0,False
Alcohol consumption (drinks per week),0.0,1.0,False
Interleukin-10 levels,0.0,1.0,False
Triptolide cytotoxicity,0.0,1.0,False
Eye morphology,0.0,1.0,False
Nose morphology,0.0,1.0,False
Feeling miserable,0.0,1.0,False
Neurociticism,0.0,1.0,False
Irritable mood,0.0,1.0,False
Feeling worry,0.0,1.0,False
Feeling hurt,0.0,1.0,False
QRS interval (sulfonylurea treatment interaction),0.0,1.0,False
Pelvic organ prolapse,0.0,1.0,False
Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia,0.0,1.0,False
Suicide attempts in schizophrenia,0.0,1.0,False
Iris color (a* coordinate),0.0,1.0,False
Suicide attempts in bipolar disorder or schizophrenia,0.0,1.0,False
Leukocyte telomere length,0.0,1.0,False
Intake of total sugars,0.0,1.0,False
Lysophosphatidylcholine levels,0.0,1.0,False
Triacylglyceride levels,0.0,1.0,False
Erosive tooth wear (severe vs non-severe),0.0,1.0,False
Acute graft versus host disease in bone marrow transplantation (recipient effect),0.0,1.0,False
Alcoholic chronic pancreatitis,0.0,1.0,False
TB-LM or TBLH-BMD (pleiotropy),0.0,1.0,False
Whole brain grey matter density,0.0,1.0,False
Sense of smell,0.0,1.0,False
Alcohol consumption (drinkers vs non-drinkers),0.0,1.0,False
Spherical equivalent (joint analysis main effects and education interaction),0.0,1.0,False
Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes,0.0,1.0,False
Body mass index (adult),0.0,1.0,False
Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,0.0,1.0,False
Bone ultrasound measurement (broadband ultrasound attenuation),0.0,1.0,False
Conotruncal heart defects (maternal effects),0.0,1.0,False
Congenital heart disease (maternal effect),0.0,1.0,False
Erosive tooth wear (severe vs none or mild),0.0,1.0,False
Cutaneous squamous cell carcinoma,0.0,1.0,False
LDL peak particle diameter (total fat intake interaction),0.0,1.0,False
Mood instability,0.0,1.0,False
Barrett's esophagus  or Esophageal adenocarcinoma,0.0,1.0,False
Smoking initiation (ever regular vs never regular),0.0,1.0,False
Nonsyndromic cleft palate,0.0,1.0,False
Intake of sweets,0.0,1.0,False
Alcohol consumption (heavy vs. light/non-drinkers),0.0,1.0,False
Perceived intensity of neohesperidin dihydrochalcone,0.0,1.0,False
Bone mineral density (Ward's triangle area),0.0,1.0,False
Appendicular lean mass,0.0,1.0,False
Iris color (L* coordinate),0.0,1.0,False
Iris heterochromicity,0.0,1.0,False
Surgical necrotising enterocolitis in extremely premature birth,0.0,1.0,False
Macrophage colony stimulating factor levels,0.0,1.0,False
Gait speed in old age,0.0,1.0,False
Interleukin-16 levels,0.0,1.0,False
Cognitive ability (MTAG),0.0,1.0,False
Cognitive ability,0.0,1.0,False
Hepcidin/transferrin saturation ratio,0.0,1.0,False
Basophil percentage of white cells,0.0,1.0,False
Recurrent major depressive disorder,0.0,1.0,False
Intelligence (MTAG),0.0,1.0,False
Cancer,0.0,1.0,False
Interferon gamma-induced protein 10 levels,0.0,1.0,False
Macrophage Migration Inhibitory Factor levels,0.0,1.0,False
Nicotine dependence symptom count,0.0,1.0,False
Interleukin-13 levels,0.0,1.0,False
Cancer (pleiotropy),0.0,1.0,False
C-reactive protein levels or triglyceride levels (pleiotropy),0.0,1.0,False
Interleukin-17 levels,0.0,1.0,False
Angiotensin-converting enzyme inhibitor intolerance,0.0,1.0,False
Interleukin-5 levels,0.0,1.0,False
Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL),0.0,1.0,False
Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction),0.0,1.0,False
C-reactive protein levels or HDL-cholesterol levels (pleiotropy),0.0,1.0,False
Monokine induced by gamma interferon levels,0.0,1.0,False
Macrophage inflammatory protein 1a levels,0.0,1.0,False
DHEAS levels,0.0,1.0,False
Iris color (b* coordinate),0.0,1.0,False
Sphingomyelin levels,0.0,1.0,False
Survival in pancreatic cancer,0.0,1.0,False
Stem cell factor levels,0.0,1.0,False
Stem cell growth factor beta levels,0.0,1.0,False
RANTES levels,0.0,1.0,False
Oropharynx cancer,0.0,1.0,False
Macrophage inflammatory protein 1b levels,0.0,1.0,False
Serum metabolite ratios in chronic kidney disease,0.0,1.0,False
Smoking behaviour (cigarette pack-years),0.0,1.0,False
White blood cell count (basophil),0.0,1.0,False
Phosphatidylcholine levels,0.0,1.0,False
Maximum habitual alcohol consumption,0.0,1.0,False
17-hydroxyprogesterone (17-OHP) levels,0.0,1.0,False
Colorectal cancer or advanced adenoma,0.0,1.0,False
Broad depression or schizophrenia,0.0,1.0,False
Serum metabolite concentrations in chronic kidney disease,0.0,1.0,False
Serum bilirubin levels in metabolic syndrome,0.0,1.0,False
Serum bilirubin levels x Mediterranean diet adherence interaction in metabolic syndrome,0.0,1.0,False
Keratinocyte cancer (MTAG),0.0,1.0,False
Feeling tense,0.0,1.0,False
Amblyopia,0.0,1.0,False
Logical memory (delayed recall) in normal cognition,0.0,1.0,False
Maximum cranial width,0.0,1.0,False
Serum folate levels,0.0,1.0,False
Urinary calcium excretion,0.0,1.0,False
Insulin-related traits (multivariate analysis),0.0,1.0,False
Help-seeking from a GP,0.0,1.0,False
Mitochondrial DNA copy number,0.0,1.0,False
Factor VII activity,0.0,1.0,False
Multisite chronic pain,0.0,1.0,False
Rapid automised naming of digits,0.0,1.0,False
Non-word reading,0.0,1.0,False
Word spelling,0.0,1.0,False
Reading ability (multivariate),0.0,1.0,False
Emphysema annual change measurement in smokers (adjusted lung density),0.0,1.0,False
Emphysema annual change measurement in smokers (percent low attenuation area),0.0,1.0,False
Toxicity response to radiotherapy in prostate cancer (hematuria) (time to event),0.0,1.0,False
BRCA1/2-negative high-risk breast cancer,0.0,1.0,False
Non-alcoholic fatty liver disease activity score,0.0,1.0,False
Bitter beverage consumption,0.0,1.0,False
Alcohol use disorder (consumption score),0.0,1.0,False
Alcohol use disorder (total score),0.0,1.0,False
Cognitive impairment test score,0.0,1.0,False
Corneal endothelial cell density,0.0,1.0,False
Corneal endothelial cell size variation coefficient,0.0,1.0,False
Maximum cranial length,0.0,1.0,False
Tea consumption,0.0,1.0,False
Varicose veins,0.0,1.0,False
Bitter non-alcoholic beverage consumption,0.0,1.0,False
Post-traumatic stress disorder (re-experiencing symptoms),0.0,1.0,False
Alanine aminotransferase levels in non-alcoholic fatty liver disease,0.0,1.0,False
Aspartate aminotransferase levels in non-alcoholic fatty liver disease,0.0,1.0,False
Liver fibrosis in non-alcoholic fatty acid liver disease,0.0,1.0,False
Neurological blood protein biomarker levels,0.0,1.0,False
Diverticular disease,0.0,1.0,False
Trauma exposure in major depressive disorder-negative individuals,0.0,1.0,False
Major depressive disorder in trauma exposed individuals,0.0,1.0,False
Total body bone mineral density (MTAG),0.0,1.0,False
Heel bone mineral density (MTAG),0.0,1.0,False
Cataracts (operation),0.0,1.0,False
Plasma free amino acid levels,0.0,1.0,False
LDL cholesterol x physical activity interaction (2df test),0.0,1.0,False
Triglycerides x physical activity interaction (2df test),0.0,1.0,False
HDL cholesterol x physical activity interaction (2df test),0.0,1.0,False
Snoring,0.0,1.0,False
Hospital contact for infections,0.0,1.0,False
Circulating leptin levels in high cardiovascular risk,0.0,1.0,False
Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,0.0,1.0,False
Glaucoma (multi-trait analysis),0.0,1.0,False
Hallux valgus,0.0,1.0,False
Proliferative diabetic retinopathy (vs NPDR and no DR),0.0,1.0,False
Proliferative diabetic retinopathy (vs no DR),0.0,1.0,False
LDL cholesterol levels x long total sleep time interaction (2df test),0.0,1.0,False
Gastrointestinal infection,0.0,1.0,False
Nasal polyps,0.0,1.0,False
Obese vs. thin,0.0,1.0,False
Morningness,0.0,1.0,False
Peginterferon alfa-2a treatment response in chronic hepatitis B infection,0.0,1.0,False
Trauma exposure,0.0,1.0,False
Major depressive disorder in trauma-unexposed individuals,0.0,1.0,False
Trauma exposure in major depressive disorder,0.0,1.0,False
Peak expiratory flow,0.0,1.0,False
White matter microstructure (axial diusivities),0.0,1.0,False
Insomnia symptoms (never/rarely vs. usually),0.0,1.0,False
Insomnia symptoms (never/rarely vs. sometimes/usually),0.0,1.0,False
FEV1,0.0,1.0,False
Age-related cognitive decline (language) (slope of z-scores),0.0,1.0,False
Automobile speeding propensity,0.0,1.0,False
Weight gain in amisulpride-treated first-episode psychosis,0.0,1.0,False
Mental composite score,0.0,1.0,False
Sleep duration (short sleep),0.0,1.0,False
Well-being spectrum (multivariate analysis),0.0,1.0,False
Social science traits (pleiotropy) (HIPO component 1),0.0,1.0,False
Lipid traits (pleiotropy) (HIPO component 1),0.0,1.0,False
Asthma exacerbations in inhaled corticosteroid treatment,0.0,1.0,False
Urolithiasis,0.0,1.0,False
Resting-state electroencephalogram vigilance,0.0,1.0,False
Cardiac troponin-I levels,0.0,1.0,False
Idiopathic intracranial hypertension,0.0,1.0,False
Diffusing capacity of carbon monoxide,0.0,1.0,False
Coronary artery disease in type 1 diabetes,0.0,1.0,False
Alzheimer's disease progression score,0.0,1.0,False
Glycemic traits (pleiotropy),0.0,1.0,False
Bisphosphonate-associated atypical femoral fracture,0.0,1.0,False
Medication use (HMG CoA reductase inhibitors),0.0,1.0,False
Medication use (glucocorticoids),0.0,1.0,False
Medication use (antiglaucoma preparations and miotics),0.0,1.0,False
Asthma (age of onset),0.0,1.0,False
Medication use (drugs used in diabetes),0.0,1.0,False
Strabismus,0.0,1.0,False
Health literacy,0.0,1.0,False
Velopharyngeal dysfunction,0.0,1.0,False
Cognitive empathy,0.0,1.0,False
Macular thickness,0.0,1.0,False
Arterial stiffness index,0.0,1.0,False
DNA methylation variation (age effect),0.0,1.0,False
Heart rate in heart failure with reduced ejection fraction,0.0,1.0,False
Breast cancer and/or colorectal cancer,0.0,1.0,False
Depression in smokers,0.0,1.0,False
Lumbar spine bone mineral density (integral),0.0,1.0,False
Smoking cessation (MTAG),0.0,1.0,False
Low susceptibility to hepatitis C infection,0.0,1.0,False
Medication use (antithrombotic agents),0.0,1.0,False
Pre-treatment viral load in HIV-1 infection,0.0,1.0,False
Osteoarthritis (self-reported),0.0,1.0,False
Alcohol consumption (drinks per week) (MTAG),0.0,1.0,False
Smoking initiation (ever regular vs never regular) (MTAG),0.0,1.0,False
Response to hepatitis B vaccine,0.0,1.0,False
3-month functional outcome in ischaemic stroke (modified Rankin score),0.0,1.0,False
Chronic obstructive pulmonary disease or high blood pressure (pleiotropy),0.0,1.0,False
Chronic obstructive pulmonary disease or resting heart rate (pleiotropy),0.0,1.0,False
Waist-to-hip ratio adjusted for BMI (additive genetic model),0.0,1.0,False
Alcohol use disorder,0.0,1.0,False
Facial wrinkles,0.0,1.0,False
Breast cancer specific mortality in estrogen receptor positive breast cancer,0.0,1.0,False
Breast cancer specific mortality in breast cancer,0.0,1.0,False
General factor of neuroticism,0.0,1.0,False
Skin reflectance (Melanin index),0.0,1.0,False
Extremely high intelligence,0.0,1.0,False
Anthropometric traits (multi-trait analysis),0.0,1.0,False
Hair morphology traits,0.0,1.0,False
Breast cancer specific mortality in estrogen receptor negative breast cancer,0.0,1.0,False
Body fat distribution (arm fat ratio),0.0,1.0,False
Upper eyelid sagging severity,0.0,1.0,False
Frontal fibrosing alopecia,0.0,1.0,False
Age of smoking initiation (MTAG),0.0,1.0,False
Initial alcohol sensitivity,0.0,1.0,False
High IL-1beta levels in gingival crevicular fluid,0.0,1.0,False
Plasma parathyroid hormone levels,0.0,1.0,False
Nicotine dependence and major depression (severity of comorbidity),0.0,1.0,False
Neonatal cytokine/chemokine levels (fetal genetic effect),0.0,1.0,False
Depression (broad),0.0,1.0,False
Morning person,0.0,1.0,False
Eudaimonic well-being,0.0,1.0,False
Endometrial cancer (endometrioid histology),0.0,1.0,False
Carpal tunnel syndrome,0.0,1.0,False
Urinary albumin excretion (no hypertensive medication),0.0,1.0,False
Seasonality and depression,0.0,1.0,False
Glycine levels,0.0,1.0,False
Circulating fibroblast growth factor 23 levels,0.0,1.0,False
Cerebrospinal AB1-42 levels in normal cognition,0.0,1.0,False
High myopia,0.0,1.0,False
Body fat distribution (leg fat ratio),0.0,1.0,False
Heart rate response to recovery post exercise,0.0,1.0,False
HDL cholesterol levels in current drinkers,0.0,1.0,False
HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),0.0,1.0,False
Depressive symptom improvement,0.0,1.0,False
Benign prostatic hyperplasia and lower urinary tract symptoms,0.0,1.0,False
Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded),0.0,1.0,False
End-stage kidney disease,0.0,1.0,False
Gut microbiota (alpha diversity),0.0,1.0,False
Gut microbiota relative abundance (bacterial taxa),0.0,1.0,False
Face memory,0.0,1.0,False
Sensorimotor dexterity,0.0,1.0,False
California verbal learning test score,0.0,1.0,False
Spatial memory,0.0,1.0,False
Spatial processing,0.0,1.0,False
HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),0.0,1.0,False
Antisaccade task score,0.0,1.0,False
Obsessive-compulsive disorder,0.0,1.0,False
Body mass index variance,0.0,1.0,False
Predicted visceral adipose tissue,0.0,1.0,False
C-reactive protein levels or total cholesterol levels (pleiotropy),0.0,1.0,False
Parental longevity (father's age at death or father's attained age),0.0,1.0,False
Non-lobar intracerebral hemorrhage (MTAG),0.0,1.0,False
Stress sensitivity (neuroticism score x major depressive disorder status interaction),0.0,1.0,False
Sulfasalazine-induced agranulocytosis,0.0,1.0,False
Urinary sodium excretion,0.0,1.0,False
Cognitive performance (processing speed),0.0,1.0,False
Cerebrospinal fluid sTREM-2 levels,0.0,1.0,False
Working memory,0.0,1.0,False
Mental health study participation (completed survey),0.0,1.0,False
Loneliness (MTAG),0.0,1.0,False
Regular attendance at a religious group,0.0,1.0,False
Asthma (time to onset),0.0,1.0,False
Waist circumference variance,0.0,1.0,False
Uveal melanoma,0.0,1.0,False
Hemoglobin A1c levels,0.0,1.0,False
Parental longevity (father's age at death),0.0,1.0,False
Parental longevity (father's attained age),0.0,1.0,False
Familial squamous cell lung carcinoma,0.0,1.0,False
Familial lung adenocarcinoma,0.0,1.0,False
Response to antidepressants (symptom improvement),0.0,1.0,False
Response to antidepressants (symptom remission),0.0,1.0,False
Lateral orbital frontal cortex volume,0.0,1.0,False
Paracentral lobule volume,0.0,1.0,False
Estimated glomerular filtration rate in diabetes,0.0,1.0,False
Estimated glomerular filtration rate in non-diabetics,0.0,1.0,False
Lateral ventricle volume,0.0,1.0,False
Childhood steroid-sensitive nephrotic syndrome,0.0,1.0,False
Pallidum volume,0.0,1.0,False
"Parental longevity (combined parental attained age, Martingale residuals)",0.0,1.0,False
Familial lung cancer,0.0,1.0,False
Putamen volume,0.0,1.0,False
HDL cholesterol and triglyceride levels,0.0,1.0,False
Age at first sexual intercourse,0.0,1.0,False
Total bilirubin levels,0.0,1.0,False
Chloride levels,0.0,1.0,False
Serum uric acid levels in response to allopurinol in gout,0.0,1.0,False
Heart rate response to exercise,0.0,1.0,False
Sodium levels,0.0,1.0,False
Blood sugar levels,0.0,1.0,False
Joint damage in rheumatoid arthritis,0.0,1.0,False
Feeling guilty,0.0,1.0,False
Experiencing mood swings,0.0,1.0,False
Self-reported risk-taking behaviour,0.0,1.0,False
Headache,0.0,1.0,False
Ankle injury,0.0,1.0,False
Total intracranial volume,0.0,1.0,False
Antipsychotic drug-induced QTc interval change in schizophrenia,0.0,1.0,False
Hip circumference variance,0.0,1.0,False
Brain region volumes,0.0,1.0,False
Cervical cancer (multi-trait analysis),0.0,1.0,False
Alanine aminotransferase levels in excessive alcohol consumption,0.0,1.0,False
Early spontaneous preterm birth,0.0,1.0,False
Pancreatic ductal adenocarcinoma,0.0,1.0,False
Erectile dysfunction,0.0,1.0,False
Age-related cognitive decline (memory) (slope of z-scores),0.0,1.0,False
Vertical cup-disc ratio (adjusted for vertical disc diameter),0.0,1.0,False
Type 2 diabetes (adjusted for BMI),0.0,1.0,False
Resistant hypertension,0.0,1.0,False
Mosaic loss of chromosome Y (Y chromosome dosage),0.0,1.0,False
Brown vs. black hair color,0.0,1.0,False
Voxel-wise structural brain imaging measurements in Alzheimerâs disease,0.0,1.0,False
Plasma anti-thyroglobulin and anti-thyroid peroxidase levels (bivariate analysis),0.0,1.0,False
Plasma anti-thyroid peroxidase levels,0.0,1.0,False
Plasma anti-thyroglobulin levels,0.0,1.0,False
"Number of decayed, missing and filled tooth surfaces or use of dentures",0.0,1.0,False
Dentures,0.0,1.0,False
Childhood obesity,0.0,1.0,False
Serum metabolite levels (CMS),0.0,1.0,False
Plasma free amino acid levels (adjusted for twenty other PFAAs),0.0,1.0,False
Brainstem volume,0.0,1.0,False
Rapid automised naming of letters,0.0,1.0,False
Triglyceride levels x long total sleep time interaction (2df test),0.0,1.0,False
LDL cholesterol levels x short total sleep time interaction (2df test),0.0,1.0,False
Gamma glutamyl transferase levels in excessive alcohol consumption,0.0,1.0,False
Smoking status (heavy vs never),0.0,1.0,False
Lung function (low FEV1 vs high FEV1),0.0,1.0,False
Infant head circumference (MTAG),0.0,1.0,False
Birth length (MTAG),0.0,1.0,False
Birth weight (MTAG),0.0,1.0,False
Physiological traits,0.0,1.0,False
Adventurousness,0.0,1.0,False
Lung function in never smokers (low FEV1 vs high FEV1),0.0,1.0,False
Gamma glutamyl transferase levels in low alcohol consumption,0.0,1.0,False
Aspartate aminotransferase levels in excessive alcohol consumption,0.0,1.0,False
Serum platinum levels after completion of cisplatin chemotherapy,0.0,1.0,False
Prostate cancer (advanced),0.0,1.0,False
"Obstructive sleep apnea trait (apnea hypopnea index, change over time)",0.0,1.0,False
Optic disc size,0.0,1.0,False
Spherical equivalent or myopia (age of diagnosis),0.0,1.0,False
Fractures,0.0,1.0,False
Worry,0.0,1.0,False
Household income (MTAG),0.0,1.0,False
Age at loss of ambulation in Duchenne muscular dystrophy,0.0,1.0,False
Uterine fibroids (multi-trait analysis),0.0,1.0,False
Alzheimer's disease (onset between ages 58 and 79),0.0,1.0,False
Mucinous adenocarcinoma in colorectal cancer,0.0,1.0,False
Spherical equivalent,0.0,1.0,False
Depressed affect,0.0,1.0,False
Gynecologic disease (multivariate analysis),0.0,1.0,False
Low tan response,0.0,1.0,False
Retinal detachment or retinal break,0.0,1.0,False
White matter microstructure (mean diusivities),0.0,1.0,False
Alzheimer's disease or HDL levels (pleiotropy),0.0,1.0,False
Spontaneous preterm birth without premature rupture of membranes,0.0,1.0,False
Spontaneous preterm birth with premature rupture of membranes,0.0,1.0,False
Moderate-to-late spontaneous preterm birth,0.0,1.0,False
Risk-taking tendency (4-domain principal component model),0.0,1.0,False
Vertical cup-disc ratio (multi-trait analysis),0.0,1.0,False
General risk tolerance (MTAG),0.0,1.0,False
Household income,0.0,1.0,False
Number of sexual partners,0.0,1.0,False
Fat-free mass,0.0,1.0,False
Blond vs. brown/black hair color,0.0,1.0,False
Red vs. brown/black hair color,0.0,1.0,False
Cytokine network levels (multivariate analysis),0.0,1.0,False
Dental caries (decayed and filled deciduous teeth),0.0,1.0,False
"Dental caries (decayed, missing and filled teeth)",0.0,1.0,False
Smoking status (ever vs never smokers),0.0,1.0,False
C-reactive protein levels or LDL-cholesterol levels (pleiotropy),0.0,1.0,False
Facial morphology (factor 19),0.0,1.0,False
Bipolar disorder or attention deficit hyperactivity disorder,0.0,1.0,False
Behcet's disease,0.0,1.0,False
Liver enzyme levels (gamma-glutamyl transferase),0.0,1.0,False
Liver enzyme levels (alanine transaminase),0.0,1.0,False
Liver enzyme levels (alkaline phosphatase),0.0,1.0,False
White blood cell types,0.0,1.0,False
Sex hormone-binding globulin levels,0.0,1.0,False
Testosterone levels,0.0,1.0,False
Disc degeneration (lumbar),0.0,1.0,False
Monocyte chemoattractant protein-1 levels,0.0,1.0,False
Amyotrophic lateral sclerosis (age of onset),0.0,1.0,False
Sunburns,0.0,1.0,False
Non-melanoma skin cancer,0.0,1.0,False
QRS duration,0.0,1.0,False
Venous thromboembolism (SNP x SNP interaction),0.0,1.0,False
Periodontal microbiota,0.0,1.0,False
Cannabis use (initiation),0.0,1.0,False
Hippocampal volume,0.0,1.0,False
Palmitoleic acid (16:1n-7) levels,0.0,1.0,False
Visceral adipose tissue adjusted for BMI,0.0,1.0,False
Visceral adipose tissue/subcutaneous adipose tissue ratio,0.0,1.0,False
Visceral fat,0.0,1.0,False
Subcutaneous adipose tissue,0.0,1.0,False
Pulmonary function decline,0.0,1.0,False
Capecitabine sensitivity,0.0,1.0,False
Urinary metabolites,0.0,1.0,False
Primary sclerosing cholangitis,0.0,1.0,False
Thyroid hormone levels,0.0,1.0,False
Alzheimer's disease (cognitive decline),0.0,1.0,False
Esophageal cancer,0.0,1.0,False
Periodontitis (Mean PAL),0.0,1.0,False
Preeclampsia,0.0,1.0,False
Caffeine consumption,0.0,1.0,False
Breast Cancer in BRCA1 mutation carriers,0.0,1.0,False
Response to anti-TNF therapy in rheumatoid arthritis,0.0,1.0,False
Educational attainment (college completion),0.0,1.0,False
Attention deficit hyperactivity disorder (time to onset),0.0,1.0,False
Cerebrospinal T-tau levels,0.0,1.0,False
Cerebrospinal P-tau181p levels,0.0,1.0,False
Cerebrospinal fluid AB1-42 levels,0.0,1.0,False
Panic disorder,0.0,1.0,False
Multiple myeloma,0.0,1.0,False
Hair morphology,0.0,1.0,False
Intracranial aneurysm,0.0,1.0,False
Primary tooth development (number of teeth),0.0,1.0,False
Primary tooth development (time to first tooth eruption),0.0,1.0,False
Quantitative traits,0.0,1.0,False
Tonometry,0.0,1.0,False
Thyroid stimulating hormone levels,0.0,1.0,False
Aortic root size,0.0,1.0,False
Hip geometry,0.0,1.0,False
Heart failure,0.0,1.0,False
Progressive supranuclear palsy,0.0,1.0,False
Self-rated health,0.0,1.0,False
Breast size,0.0,1.0,False
HIV-1 susceptibility,0.0,1.0,False
Biochemical measures,0.0,1.0,False
Suicide attempts in bipolar disorder,0.0,1.0,False
Periodontitis (CDC/AAP),0.0,1.0,False
Information processing speed,0.0,1.0,False
Sphingolipid levels,0.0,1.0,False
Pulmonary function (smoking interaction),0.0,1.0,False
Follicular lymphoma,0.0,1.0,False
Celiac disease or Rheumatoid arthritis,0.0,1.0,False
Hirschsprung disease,0.0,1.0,False
Gout,0.0,1.0,False
Erectile dysfunction and prostate cancer treatment,0.0,1.0,False
Educational attainment,0.0,1.0,False
Periodontitis (DPAL),0.0,1.0,False
Femoral neck bone mineral density,0.0,1.0,False
Plasma omega-3 polyunsaturated fatty acid level (eicosapentaenoic acid),0.0,1.0,False
Plasma omega-3 polyunsaturated fatty acid levels (docosapentaenoic acid),0.0,1.0,False
Lung function (FEV1),0.0,1.0,False
Lung function (forced expiratory flow during mid-portion (25% and 75%) of forced vital capacity),0.0,1.0,False
Lipid traits,0.0,1.0,False
Mortality in heart failure,0.0,1.0,False
vWF and FVIII levels,0.0,1.0,False
Abdominal aortic aneurysm,0.0,1.0,False
Alopecia areata,0.0,1.0,False
Bulimia nervosa,0.0,1.0,False
Eating disorders,0.0,1.0,False
Post-traumatic stress disorder (asjusted for relatedness),0.0,1.0,False
D-dimer levels,0.0,1.0,False
Adverse response to lamotrigine and phenytoin,0.0,1.0,False
Plasma omega-3 polyunsaturated fatty acid levels (alphalinolenic acid),0.0,1.0,False
Endometrial cancer,0.0,1.0,False
Preschool internalizing problems,0.0,1.0,False
Serum thyroid-stimulating hormone levels,0.0,1.0,False
Cholesterol,0.0,1.0,False
Age-related hearing impairment (SNP x SNP interaction),0.0,1.0,False
Osteoarthritis (hip),0.0,1.0,False
Response to antipsychotic therapy (extrapyramidal side effects),0.0,1.0,False
Cognitive decline (age-related),0.0,1.0,False
Fractional exhaled nitric oxide (childhood),0.0,1.0,False
Free thyroxine concentration,0.0,1.0,False
Methotrexate phramacokinetics (acute lymphoblastic leukemia),0.0,1.0,False
Blood metabolite ratios,0.0,1.0,False
Alcohol dependence (age at onset),0.0,1.0,False
Sleep duration,0.0,1.0,False
Blood metabolite levels,0.0,1.0,False
Mitochondrial DNA levels,0.0,1.0,False
Glomerular filtration rate,0.0,1.0,False
Multiple myeloma (IgH translocation),0.0,1.0,False
Peripheral artery disease,0.0,1.0,False
Response to tocilizumab in rheumatoid arthritis,0.0,1.0,False
"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)",0.0,1.0,False
Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy),0.0,1.0,False
Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy),0.0,1.0,False
Amyotrophic lateral sclerosis (sporadic),0.0,1.0,False
Serum metabolite levels,0.0,1.0,False
Urinary metabolites (H-NMR features),0.0,1.0,False
Social communication problems,0.0,1.0,False
Word reading,0.0,1.0,False
Migraine - clinic-based,0.0,1.0,False
Post-traumatic stress disorder,0.0,1.0,False
Intraocular pressure,0.0,1.0,False
Factor VIII levels,0.0,1.0,False
vWF levels,0.0,1.0,False
Vascular endothelial growth factor levels,0.0,1.0,False
Bipolar disorder with mood-incongruent psychosis,0.0,1.0,False
Frontotemporal dementia,0.0,1.0,False
Immune reponse to smallpox (secreted IL-2),0.0,1.0,False
Immune reponse to smallpox (secreted IL-1beta),0.0,1.0,False
Immune reponse to smallpox (secreted IFN-alpha),0.0,1.0,False
Gamma glutamyl transferase levels,0.0,1.0,False
Economic and political preferences,0.0,1.0,False
Metabolite levels (Pyroglutamine),0.0,1.0,False
Lumbar spine bone mineral density,0.0,1.0,False
Metabolite levels (Dihydroxy docosatrienoic acid),0.0,1.0,False
Cognitive function,0.0,1.0,False
Immune response to smallpox vaccine (IL-6),0.0,1.0,False
Dialysis-related mortality,0.0,1.0,False
Homeostasis model assessment of insulin resistance (dietary factor interaction),0.0,1.0,False
Metabolite levels  (X-11787),0.0,1.0,False
Hypertriglyceridemia,0.0,1.0,False
Phospholipid levels (plasma),0.0,1.0,False
Anorexia nervosa,0.0,1.0,False
Brain structure,0.0,1.0,False
Vertical cup-disc ratio,0.0,1.0,False
Telomere length,0.0,1.0,False
Type 2 diabetes nephropathy,0.0,1.0,False
Fasting blood glucose,0.0,1.0,False
Homeostasis model assessment of beta-cell function,0.0,1.0,False
Chronic lymphocytic leukemia,0.0,1.0,False
Menopause (age at onset),0.0,1.0,False
Fibrinogen,0.0,1.0,False
Nasopharyngeal carcinoma,0.0,1.0,False
Hippocampal atrophy,0.0,1.0,False
Obesity (extreme),0.0,1.0,False
HIV-1 control,0.0,1.0,False
Heart rate,0.0,1.0,False
Kidney stones,0.0,1.0,False
Adiponectin levels,0.0,1.0,False
C-reactive protein,0.0,1.0,False
Attention deficit hyperactivity disorder,0.0,1.0,False
Electrocardiographic traits,0.0,1.0,False
Response to antipsychotic treatment,0.0,1.0,False
Platelet aggregation,0.0,1.0,False
Diabetic retinopathy,0.0,1.0,False
Renal cell carcinoma,0.0,1.0,False
Metabolic syndrome,0.0,1.0,False
Parkinson's disease,0.0,1.0,False
PR interval,0.0,1.0,False
Pancreatic cancer,0.0,1.0,False
Refractive error,0.0,1.0,False
Coronary heart disease,0.0,1.0,False
Calcium levels,0.0,1.0,False
Response to treatment for acute lymphoblastic leukemia,0.0,1.0,False
Moyamoya disease,0.0,1.0,False
Non-small cell lung cancer,0.0,1.0,False
Inflammatory biomarkers,0.0,1.0,False
"Cholesterol, total",0.0,1.0,False
Warfarin maintenance dose,0.0,1.0,False
Sudden cardiac arrest,0.0,1.0,False
Tuberculosis,0.0,1.0,False
Magnesium levels,0.0,1.0,False
Nicotine dependence,0.0,1.0,False
Pulmonary function,0.0,1.0,False
Colorectal cancer,0.0,1.0,False
Prostate-specific antigen levels,0.0,1.0,False
Glioma,0.0,1.0,False
Bone mineral density (hip),0.0,1.0,False
Bone mineral density (spine),0.0,1.0,False
Cardiac hypertrophy,0.0,1.0,False
Idiopathic dilated cardiomyopathy,0.0,1.0,False
Idiopathic membranous nephropathy,0.0,1.0,False
Endometriosis,0.0,1.0,False
Caudate nucleus volume,0.0,1.0,False
Corneal astigmatism,0.0,1.0,False
Idiopathic pulmonary fibrosis,0.0,1.0,False
Venous thromboembolism,0.0,1.0,False
QT interval,0.0,1.0,False
Chronic obstructive pulmonary disease,0.0,1.0,False
Glaucoma,0.0,1.0,False
Chronic kidney disease,0.0,1.0,False
Obesity,0.0,1.0,False
Iron status biomarkers,0.0,1.0,False
Gallstone disease,0.0,1.0,False
Uric acid levels,0.0,1.0,False
Type 2 diabetes,0.0,1.0,False
Response to hepatitis C treatment,0.0,1.0,False
Metabolic traits,0.0,1.0,False
Lipoprotein-associated phospholipase A2 activity and mass,0.0,1.0,False
Lung adenocarcinoma,0.0,1.0,False
Tanning,0.0,1.0,False
Ovarian cancer,0.0,1.0,False
Smoking behavior,0.0,1.0,False
Orofacial clefts,0.0,1.0,False
Basal cell carcinoma,0.0,1.0,False
Nodular sclerosis Hodgkin lymphoma,0.0,1.0,False
Airflow obstruction,0.0,1.0,False
Migraine,0.0,1.0,False
Response to antipsychotic treatment in schizophrenia (working memory),0.0,1.0,False
Clozapine-induced agranulocytosis,0.0,1.0,False
Gastric cancer,0.0,1.0,False
Homocysteine levels,0.0,1.0,False
Bilirubin levels,0.0,1.0,False
Metabolite levels (HVA),0.0,1.0,False
Metabolite levels (MHPG),0.0,1.0,False
Metabolite levels (HVA/MHPG ratio),0.0,1.0,False
Axial length,0.0,1.0,False
Optic disc area,0.0,1.0,False
Urinary albumin excretion,0.0,1.0,False
Hemostatic factors and hematological phenotypes,0.0,1.0,False
Nonalcoholic fatty liver disease,0.0,1.0,False
Hyperactive-impulsive symptoms,0.0,1.0,False
Hepatitis B,0.0,1.0,False
Liver enzyme levels,0.0,1.0,False
Common traits (Other),0.0,1.0,False
Protein C levels,0.0,1.0,False
Non-alcoholic fatty liver disease histology (lobular),0.0,1.0,False
Hematological and biochemical traits,0.0,1.0,False
Obesity (early onset extreme),0.0,1.0,False
Hemoglobin,0.0,1.0,False
Hematocrit,0.0,1.0,False
Anthropometric traits,0.0,1.0,False
Prostate cancer (SNP x SNP interaction),0.0,1.0,False
Corneal structure,0.0,1.0,False
Select biomarker traits,0.0,1.0,False
Atopic dermatitis,0.0,1.0,False
Myopia,0.0,1.0,False
Prothrombin time,0.0,1.0,False
Graves' disease,0.0,1.0,False
Age-related macular degeneration,0.0,1.0,False
Glioblastoma,0.0,1.0,False
Glaucoma (primary open-angle),0.0,1.0,False
Response to statin therapy,0.0,1.0,False
Tourette syndrome,0.0,1.0,False
Pit-and-Fissure caries,0.0,1.0,False
Renal function-related traits (BUN),0.0,1.0,False
Malaria,0.0,1.0,False
Resting heart rate,0.0,1.0,False
End-stage coagulation,0.0,1.0,False
Essential tremor,0.0,1.0,False
Lipid metabolism phenotypes,0.0,1.0,False
HDL cholesterol levels,0.0,1.0,False
Hematological parameters,0.0,1.0,False
Cognitive performance,0.0,1.0,False
Hypospadias,0.0,1.0,False
Knee osteoarthritis,0.0,1.0,False
DNA methylation (variation),0.0,1.0,False
Hematology traits,0.0,1.0,False
Vitamin D levels,0.0,1.0,False
Eye color,0.0,1.0,False
Coronary artery calcification,0.0,1.0,False
Squamous cell carcinoma,0.0,1.0,False
Activated partial thromboplastin time,0.0,1.0,False
Interstitial lung disease,0.0,1.0,False
Cardiovascular disease risk factors,0.0,1.0,False
Central corneal thickness,0.0,1.0,False
Personality dimensions,0.0,1.0,False
Attention deficit hyperactivity disorder and conduct disorder,0.0,1.0,False
Ankylosing spondylitis,0.0,1.0,False
Pubertal anthropometrics,0.0,1.0,False
Presence of antiphospholipid antibodies,0.0,1.0,False
Bipolar disorder (body mass index interaction),0.0,1.0,False
Lupus nephritis in systemic lupus erythematosus,0.0,1.0,False
Generalized epilepsy,0.0,1.0,False
Autism spectrum disorder or schizophrenia,0.0,1.0,False
Neurocognitive impairment in HIV-1 infection (dichotomous),0.0,1.0,False
Craniofacial microsomia,0.0,1.0,False
Autism spectrum disorder,0.0,1.0,False
Small cell lung carcinoma,0.0,1.0,False
Squamous cell lung carcinoma,0.0,1.0,False
Childhood ear infection,0.0,1.0,False
Rubella,0.0,1.0,False
Mononucleosis,0.0,1.0,False
Subjective well-being (MTAG),0.0,1.0,False
Depressive symptoms (MTAG),0.0,1.0,False
Borderline personality disorder,0.0,1.0,False
Lung cancer in never smokers,0.0,1.0,False
Subjective well-being,0.0,1.0,False
Heart rate variability traits (SDNN),0.0,1.0,False
Strep throat,0.0,1.0,False
Neuroticism (MTAG),0.0,1.0,False
Red blood cell density in sickle cell anemia,0.0,1.0,False
Chickenpox,0.0,1.0,False
Bacterial meningitis,0.0,1.0,False
Peripheral arterial disease (traffic-related air pollution interaction),0.0,1.0,False
Trunk fat mass,0.0,1.0,False
Facial morphology (factor 16),0.0,1.0,False
"Facial morphology (factor 17, height of vermillion upper lip)",0.0,1.0,False
Facial morphology (factor 18),0.0,1.0,False
Facial morphology (factor 20),0.0,1.0,False
"Facial morphology (factor 2, vertical position of orbits relative to midface)",0.0,1.0,False
Smoking status,0.0,1.0,False
Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction),0.0,1.0,False
"Facial morphology (factor 8, orbital inclination due to vertical and horizontal position of exocanthion)",0.0,1.0,False
Depressive symptoms,0.0,1.0,False
Heart rate variability traits (RMSSD),0.0,1.0,False
Mumps,0.0,1.0,False
Plantar warts,0.0,1.0,False
Thrombosis,0.0,1.0,False
Morning vs. evening chronotype,0.0,1.0,False
Cognitive decline rate in late mild cognitive impairment,0.0,1.0,False
Cerebral amyloid deposition in APOEe4 non-carriers (PET imaging),0.0,1.0,False
Cerebrospinal fluid t-tau:AB1-42 ratio,0.0,1.0,False
Body fat percentage,0.0,1.0,False
Colonoscopy-negative controls vs population controls,0.0,1.0,False
Body mass index in physically active individuals,0.0,1.0,False
Waist circumference adjusted for BMI in active individuals,0.0,1.0,False
Waist circumference adjusted for BMI (adjusted for smoking behaviour),0.0,1.0,False
Body mass index in physically inactive individuals,0.0,1.0,False
Lipoprotein (a) levels,0.0,1.0,False
Caudate activity during reward,0.0,1.0,False
Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),0.0,1.0,False
BMI in non-smokers,0.0,1.0,False
Waist circumference adjusted for BMI in smokers,0.0,1.0,False
Number of common colds,0.0,1.0,False
Waist circumference adjusted for BMI in non-smokers,0.0,1.0,False
Cold sores,0.0,1.0,False
Shingles,0.0,1.0,False
Body mass index (joint analysis main effects and smoking interaction),0.0,1.0,False
BMI (adjusted for smoking behaviour),0.0,1.0,False
Urinary tract infection frequency,0.0,1.0,False
"Facial morphology (factor 4, facial height related to vertical position of gnathion)",0.0,1.0,False
BMI in smokers,0.0,1.0,False
Measles,0.0,1.0,False
Myringotomy,0.0,1.0,False
Yeast infection,0.0,1.0,False
Rheumatic fever,0.0,1.0,False
Hepatitis A,0.0,1.0,False
Chronic sinus infection,0.0,1.0,False
Gestational age at birth (maternal effect),0.0,1.0,False
"Facial morphology (factor 6, height of vermillion lower lip)",0.0,1.0,False
"Facial morphology (factor 11, projection of the nose)",0.0,1.0,False
"Facial morphology (factor 14, intercanthal width)",0.0,1.0,False
Epilepsy and lamotrigine-induced maculopapular eruptions,0.0,1.0,False
Attention function in attention deficit hyperactive disorder,0.0,1.0,False
Hemoglobin levels,0.0,1.0,False
Microalbuminuria,0.0,1.0,False
Cough in response to angiotensin-converting enzyme inhibitor drugs,0.0,1.0,False
Coronary artery aneurysm in Kawasaki disease,0.0,1.0,False
Cutaneous malignant melanoma,0.0,1.0,False
Mild influenza (H1N1) infection,0.0,1.0,False
Severe influenza A (H1N1) infection,0.0,1.0,False
Influenza A (H1N1) infection,0.0,1.0,False
Suicide attempts in major depressive disorder,0.0,1.0,False
Cerebrospinal fluid clusterin levels,0.0,1.0,False
Response to paliperidone in schizophrenia (positive Marder score),0.0,1.0,False
Response to paliperidone in schizophrenia (negative Marder score),0.0,1.0,False
Left atrial antero-posterior diameter,0.0,1.0,False
Left ventricle wall thickness,0.0,1.0,False
Cleft palate,0.0,1.0,False
Life satisfaction,0.0,1.0,False
Positive affect,0.0,1.0,False
Depression,0.0,1.0,False
Metabolite levels (lipoprotein measures),0.0,1.0,False
Metabolite levels (small molecules and protein measures),0.0,1.0,False
Aggressiveness in attention deficit hyperactivity disorder,0.0,1.0,False
Neuritic plaque,0.0,1.0,False
Cleft lip with or without cleft palate,0.0,1.0,False
Response to paliperidone in schizophrenia (CGI-S score),0.0,1.0,False
Hemoglobin concentration,0.0,1.0,False
Response to paliperidone in schizophrenia (PANSS score),0.0,1.0,False
Gut microbiota (functional units),0.0,1.0,False
Prostate-specific antigen levels (conditioned on lead SNPs),0.0,1.0,False
Age-related disease endophenotypes,0.0,1.0,False
Body fat mass,0.0,1.0,False
Gut microbiome composition (winter),0.0,1.0,False
Lewy body disease,0.0,1.0,False
Diabetic kidney disease,0.0,1.0,False
Facial morphology (factor 23),0.0,1.0,False
"Facial morphology (factor 21, depth of nasal alae)",0.0,1.0,False
6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction),0.0,1.0,False
Tenofovir clearance in HIV infection,0.0,1.0,False
Gut microbiome composition (summer),0.0,1.0,False
Eyebrow thickness,0.0,1.0,False
Glomerular filtration rate in non diabetics (creatinine),0.0,1.0,False
Exploratory eye movement dysfunction in schizophrenia (responsive search score),0.0,1.0,False
Exploratory eye movement dysfunction in schizophrenia (number of eye fixations),0.0,1.0,False
Exploratory eye movement dysfunction in schizophrenia (cognitive search score),0.0,1.0,False
Cerebral amyloid deposition (PET imaging),0.0,1.0,False
Midgestational circulating levels of PBDEs (fetal genetic effect),0.0,1.0,False
Nonsyndromic cleft lip with cleft palate,0.0,1.0,False
Loneliness (multivariate analysis),0.0,1.0,False
Venous thromboembolism adjusted for sickle cell variant rs77121243-T,0.0,1.0,False
Urinary albumin-to-creatinine ratio,0.0,1.0,False
Emphysema imaging phenotypes,0.0,1.0,False
Pediatric bone mineral content (radius),0.0,1.0,False
Colorectal or endometrial cancer,0.0,1.0,False
Nose size,0.0,1.0,False
Joint mobility (Beighton score),0.0,1.0,False
Gut microbiota (beta diversity),0.0,1.0,False
Gut microbiota (bacterial taxa),0.0,1.0,False
Glomerular filtration rate in chronic kidney disease,0.0,1.0,False
Monobrow,0.0,1.0,False
Chin dimples,0.0,1.0,False
Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder,0.0,1.0,False
Classic bladder exstrophy,0.0,1.0,False
Response to zileuton treatment in asthma (FEV1 change interaction),0.0,1.0,False
Dementia and core Alzheimer's disease neuropathologic changes,0.0,1.0,False
Percentage gas trapping,0.0,1.0,False
Photic sneeze reflex,0.0,1.0,False
Bone mineral density (total hip),0.0,1.0,False
Ischemic stroke (large artery atherosclerosis),0.0,1.0,False
Post bronchodilator FEV1 in COPD,0.0,1.0,False
Asymmetrical dimethylarginine levels,0.0,1.0,False
Symmetrical dimethylarginine levels,0.0,1.0,False
Esophageal adenocarcinoma,0.0,1.0,False
Barrett's esophagus,0.0,1.0,False
Smoking cessation,0.0,1.0,False
Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid),0.0,1.0,False
Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid),0.0,1.0,False
Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid),0.0,1.0,False
Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid),0.0,1.0,False
Acne (severe),0.0,1.0,False
Smoking initiation,0.0,1.0,False
Age of smoking initiation,0.0,1.0,False
Behavioural disinhibition (generation interaction),0.0,1.0,False
Anger,0.0,1.0,False
Red blood cell fatty acid levels,0.0,1.0,False
Asthma and hay fever,0.0,1.0,False
Response to efavirenz-containing treatment in HIV 1 infection (virologic failure),0.0,1.0,False
Response to abacavir-containing treatment in HIV-1 infection (virologic failure),0.0,1.0,False
Carotid intima media thickness,0.0,1.0,False
Very long-chain saturated fatty acid levels (fatty acid 20:0),0.0,1.0,False
Urate levels in overweight individuals,0.0,1.0,False
Urate levels in obese individuals,0.0,1.0,False
Iron status biomarkers (ferritin levels),0.0,1.0,False
Iron status biomarkers (transferrin saturation),0.0,1.0,False
Iron status biomarkers (iron levels),0.0,1.0,False
Optic cup area,0.0,1.0,False
Motion sickness,0.0,1.0,False
Serum dimethylarginine levels (asymmetric/symetric ratio),0.0,1.0,False
Insomnia,0.0,1.0,False
Hand grip strength,0.0,1.0,False
Myocardial infarction,0.0,1.0,False
Toenail selenium levels,0.0,1.0,False
Electroencephalogram traits,0.0,1.0,False
Blood pressure (smoking interaction),0.0,1.0,False
Serum alkaline phosphatase levels,0.0,1.0,False
"Bone mineral density (paediatric, total body less head)",0.0,1.0,False
Corneal curvature,0.0,1.0,False
Psychosis (atypical),0.0,1.0,False
Response to cytadine analogues (cytosine arabinoside),0.0,1.0,False
Cocaine dependence,0.0,1.0,False
Bronchopulmonary dysplasia,0.0,1.0,False
Refractive astigmatism,0.0,1.0,False
Response to statins (LDL cholesterol change),0.0,1.0,False
Chagas cardiomyopathy in Tripanosoma cruzi seropositivity,0.0,1.0,False
Antibody status in Tripanosoma cruzi seropositivity,0.0,1.0,False
Ejection fraction in Tripanosoma cruzi seropositivity,0.0,1.0,False
Self-reported allergy,0.0,1.0,False
Antineutrophil cytoplasmic antibody-associated vasculitis,0.0,1.0,False
Facial morphology,0.0,1.0,False
Temperament,0.0,1.0,False
Ischemic stroke,0.0,1.0,False
Epithelial ovarian cancer,0.0,1.0,False
Phosphorus levels,0.0,1.0,False
Migraine with aura,0.0,1.0,False
Migraine without aura,0.0,1.0,False
Parasitemia in Tripanosoma cruzi seropositivity,0.0,1.0,False
QRS duration in Tripanosoma cruzi seropositivity,0.0,1.0,False
Total bilirubin levels in HIV-1 infection,0.0,1.0,False
Fasting blood glucose (BMI interaction),0.0,1.0,False
Response to platinum-based chemotherapy (cisplatin),0.0,1.0,False
Response to platinum-based chemotherapy (carboplatin),0.0,1.0,False
White matter hyperintensity burden,0.0,1.0,False
Coronary artery disease or large artery stroke,0.0,1.0,False
Coronary artery disease or ischemic stroke,0.0,1.0,False
Large artery stroke,0.0,1.0,False
Fasting blood insulin (BMI interaction),0.0,1.0,False
Chronic obstructive pulmonary disease-related biomarkers,0.0,1.0,False
Serum total protein level,0.0,1.0,False
Elevated serum carcinoembryonic antigen levels,0.0,1.0,False
Western dietary pattern,0.0,1.0,False
Systolic blood pressure x smoking status (current vs non-current) interaction (2df test),0.0,1.0,False
Heart rate response to beta blockers (atenolol monotherapy),0.0,1.0,False
Waist-to-hip ratio adjusted for BMI (age <50),0.0,1.0,False
Multiple system atrophy,0.0,1.0,False
Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test),0.0,1.0,False
Limited cutaneous systemic scleroderma,0.0,1.0,False
Non-glioblastoma glioma,0.0,1.0,False
Heart rate response to recovery post exercise (40 sec),0.0,1.0,False
Heart rate response to recovery post exercise (50 sec),0.0,1.0,False
Heart rate response to recovery post exercise (30 sec),0.0,1.0,False
Heart rate response to recovery post exercise (20 sec),0.0,1.0,False
Hyperuricemia,0.0,1.0,False
Fasting blood glucose adjusted for BMI,0.0,1.0,False
Body mass index x sex x age interaction (4df test),0.0,1.0,False
Coronary atherosclerosis (increased number of diseased vessels) (traffic exposure interaction),0.0,1.0,False
Body mass index (joint analysis main effects and physical activity interaction),0.0,1.0,False
Glomerular filtration rate (creatinine),0.0,1.0,False
Hip circumference,0.0,1.0,False
Trans fatty acid levels,0.0,1.0,False
Lipoprotein phospholipase A2 activity in cardiovascular disease,0.0,1.0,False
Major depression and alcohol dependence,0.0,1.0,False
Obstructive sleep apnea trait (apnea hypopnea index),0.0,1.0,False
Prudent dietary pattern,0.0,1.0,False
Carboplatin disposition in epthelial ovarian cancer,0.0,1.0,False
Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction),0.0,1.0,False
Initial pursuit acceleration in psychotic disorders,0.0,1.0,False
Idiopathic osteonecrosis of the femoral head,0.0,1.0,False
"B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)",0.0,1.0,False
Initial pursuit acceleration,0.0,1.0,False
GIP levels in response to oral glucose tolerance test (120 minutes),0.0,1.0,False
Paclitaxel disposition in epithelial ovarian cancer,0.0,1.0,False
Alzheimer disease and age of onset,0.0,1.0,False
Post bronchodilator FEV1/FVC ratio in COPD,0.0,1.0,False
Serous invasive ovarian cancer,0.0,1.0,False
P wave duration,0.0,1.0,False
Anti-saccade response,0.0,1.0,False
Age-related nuclear cataracts,0.0,1.0,False
Urate levels in lean individuals,0.0,1.0,False
Sitting height ratio,0.0,1.0,False
Nasopharyngeal carcinoma (SNP x SNP interaction),0.0,1.0,False
Clozapine-induced cytotoxicity,0.0,1.0,False
Complement C3 and C4 levels,0.0,1.0,False
Spontaneous preterm birth (preterm birth),0.0,1.0,False
Polychlorinated biphenyl levels,0.0,1.0,False
Anxiety disorder,0.0,1.0,False
Thiazide-induced adverse metabolic effects in hypertensive patients,0.0,1.0,False
Lead levels in blood,0.0,1.0,False
Cardiac Troponin-T levels,0.0,1.0,False
Alzheimer's disease in APOE e4+ carriers,0.0,1.0,False
Nonsyndromic cleft lip with or without cleft palate,0.0,1.0,False
Response to serotonin reuptake inhibitors in major depressive disorder,0.0,1.0,False
Blood osmolality (transformed sodium),0.0,1.0,False
Systolic blood pressure x smoking status (ever vs never) interaction (2df test),0.0,1.0,False
Invasive epithelial ovarian cancer,0.0,1.0,False
Body mass index (age <50),0.0,1.0,False
Basophil percentage of granulocytes,0.0,1.0,False
Diastolic blood pressure x smoking status (ever vs never) interaction (2df test),0.0,1.0,False
High-grade serous ovarian cancer,0.0,1.0,False
Alcohol dependence symptom count,0.0,1.0,False
Tumor necrosis factor alpha levels,0.0,1.0,False
Stromal-cell-derived factor 1 alpha levels,0.0,1.0,False
TRAIL levels,0.0,1.0,False
Type 1 diabetes and autoimmune thyroid diseases,0.0,1.0,False
Verbal declarative memory,0.0,1.0,False
Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab),0.0,1.0,False
Iron status biomarkers (total iron binding capacity),0.0,1.0,False
Age at menopause,0.0,1.0,False
